Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease

NCT07713875 is registered in ClinicalTrials.gov with James Bayley as lead sponsor.

NCT NCT07713875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07713875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
Lead sponsor
James Bayley
Phase
Phase 4
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis (dvt), pulmonary embolism (pe), spine metastasis, venous thromboembolism (vte)